Naro Babaian Marukian, O.D.
Optometrist · Van Nuys, CA
Naro Babaian Marukian, O.D. is an optometrist with a practice address in Van Nuys, California, and NPI 1770998882, issued on Jun 26, 2014. Check the license (California 14959, as entered in NPPES) with the California board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Naro Babaian Marukian
- Credential
- O.D.
- Primary taxonomy
- Optometrist 152W00000X
- License number
- 14959 CA
Self-reported in NPPES; status is on the state search - Practice location
- 7500 Van Nuys Blvd, Van Nuys, CA 91405
- Phone
- (661) 775-1860
- Enumerated
- Jun 26, 2014
- Record last updated
- May 11, 2026
- Medicare enrollment
- Enrolled (PECOS I20160401001640); accepts Medicare assignment
- Entity
- Type 1 · individual
Verify Naro Babaian Marukian in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich California board licenses this profession
Search for license 14959Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
21% fewer Medicare Part D claims than the average optometrist in 2024
219 Medicare Part D claims for 49 beneficiaries, against an average of 277 among the 33,128 providers of this specialty who prescribed in Part D. Brand-name drugs were 53% of claims.
Most prescribed
- Latanoprost163 claims
- Cyclosporine20 claims
- Timolol Maleate12 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Bills Medicare through one group practice
- County OF Los AngelesCompton, CA
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Optometrist providers in California
There are 8,308 optometrist records in California.
Other optometrist records in California
- Douglas Aaseby, O.D.El Dorado Hills, CA1962715961
- Saloumeh Abadi, ODSanta Monica, CA1699258756
- Davoud AbbasiFillmore, CA1902361678
- Christopher Abbott, O.D.Santee, CA1417936220
- Sara Abboud, ODAlbany, CA1649052846
- Ghezal Abdali, O.D.Tustin, CA1770688640
- Nahid Abdali, O.D.San Ramon, CA1700210242
- Yasmeen AbdelfattahIrvine, CA1417786617
- Marina Abdou, ODUpland, CA1356017321
- Angela Abe, OPTModesto, CA1336108885
Common questions
What is Naro Babaian Marukian, O.D.'s NPI number?
Naro Babaian Marukian, O.D.'s National Provider Identifier (NPI) is 1770998882, issued on Jun 26, 2014. An NPI identifies a provider in billing; it is not a license.
Where is Naro Babaian Marukian, O.D. located?
The NPPES record lists a practice address at 7500 Van Nuys Blvd, Van Nuys, CA, 91405. Phone: (661) 775-1860. Providers update this record themselves, so call before visiting.
How can I verify Naro Babaian Marukian, O.D.'s license?
NPPES lists California license number 14959, as entered by the provider. Search the California board that licenses this profession; the NPPES record confirms identity only.
How much does Naro Babaian Marukian, O.D. prescribe under Medicare Part D?
In 2024, Naro Babaian Marukian, O.D. had 219 Medicare Part D claims for 49 beneficiaries; the average among optometrist prescribers was 277. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.